JLJiayi Li

Jiayi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiayi Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nitric oxide promotes Arc turnover via protein S-Nitrosylation

    by Peng Zhang, Jingyi Wang, Li Wang, Jie Wang, Yulu Lin, Jiayi Li, Xinke Gao, Yuchen Li, Kun Zhang, Yanfei Han, et al.

    The activity-dependent turnover of the immediate-early gene product Arc contributes to synaptic plasticity by regulating AMPA receptor trafficking. Although Arc transcription and translation have been extensively studied, the mechanisms governing its rapid degradation remain incompletely understood. Here, using quantitative proteomics together with cultured neurons and an in vivo fear-conditioning paradigm, we identify neuronal nitric oxide synthase (nNOS)-derived nitric oxide (NO) as a regulator of activity-induced Arc turnover. Our findings indicate that NO promotes Arc degradation through S-Nitrosylation at Cys96 and Cys159. Mutation of these residues attenuated NO-dependent Arc turnover, prolonged Arc abundance, and enhanced AMPA receptor internalization. Thus, nNOS-derived NO may function as a temporal regulator that fine-tunes the duration of Arc-dependent synaptic signaling and helps maintain AMPA receptor homeostasis.

  • Open Access

    S-Nitrosylation of p39 promotes its degradation and contributes to synaptic dysfunction induced by β-amyloid peptide

    by Aobing Cheng, Jingyi Wang, Jiayi Li, Jie Wang, Mufan Xu, Hongzhuan Chen, Peng Zhang

    Alzheimer’s disease (AD), characterized by cognitive decline, is increasingly recognized as a disorder marked by synaptic loss and dysfunction. Despite this understanding, the underlying pathophysiological mechanisms contributing to synaptic impairment remain largely unknown. In this study, we elucidate a previously undiscovered signaling pathway wherein the S-nitrosylation of the Cdk5 activator p39, a post-translational modification involving the addition of nitric oxide to protein cysteine residues, plays a crucial role in synaptic dysfunction associated with AD. Our investigation reveals heightened p39 S-nitrosylation in the brain of an amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model of AD. Additionally, soluble amyloid-β oligomers (Aβ), implicated in synaptic loss in AD, induce p39 S-nitrosylation in cultured neurons. Notably, we uncover that p39 protein level is regulated by S-nitrosylation, with nitric oxide S-nitrosylating p39 at Cys265 and subsequently promoting its degradation. Furthermore, our study demonstrates that S-nitrosylation of p39 at Cys265 significantly contributes to amyloid-β (Aβ) peptide-induced dendrite retraction and spine loss. Collectively, our findings highlight S-nitrosylation of p39 as a novel aberrant redox protein modification involved in the pathogenesis of AD, suggesting its potential as a therapeutic target for the disease.